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Abstract
Background: The aim of this study was to estimate the seroprevalence of Coxiella burnetii in dairy goat farms in
the Netherlands and to identify risk factors for farm and goat seropositivity before mandatory vaccination started.
We approached 334 eligible farms with more than 100 goats for serum sampling and a farm questionnaire. Per
farm, median 21 goats were sampled. A farm was considered positive when at least one goat tested ELISA positive.
Results: In total, 2,828 goat serum samples from 123 farms were available. Farm prevalence was 43.1% (95%CI:
34.3%-51.8%). Overall goat seroprevalence was 21.4% (95%CI: 19.9%-22.9%) and among the 53 positive farms 46.6%
(95%CI: 43.8%-49.3%). Multivariable logistic regression analysis included 96 farms and showed that farm location
within 8 kilometres proximity from a bulk milk PCR positive farm, location in a municipality with high cattle density
(≥ 100 cattle per square kilometre), controlling nuisance animals through covering airspaces, presence of cats or
dogs in the goat stable, straw imported from abroad or unknown origin and a herd size above 800 goats were
independent risk factors associated with Q fever on farm level. At animal level almost identical risk factors were
found, with use of windbreak curtain and artificial insemination as additional risk factors.
Conclusion: In 2009-2010, the seroprevalence in dairy goats in the Netherlands increased on animal and farm level
compared to a previous study in 2008. Risk factors suggest spread from relatively closely located bulk milk-infected
small ruminant farms, next to introduction and spread from companion animals, imported straw and use of
artificial insemination. In-depth studies investigating the role of artificial insemination and bedding material are
needed, while simultaneously general biosecurity measures should be updated, such as avoiding companion
animals and vermin entering the stables, next to advice on farm stable constructions on how to prevent
introduction and minimize airborne transmission from affected dairy goat farms to prevent further spread to the
near environment.
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Background
Q fever is a zoonosis caused by Coxiella burnetii,a n
intracellular Gram-negative bacterium. From spring
2007 until the end of 2009, large community outbreaks
of Q fever with over 3500 notified cases occurred in the
Dutch population, mainly in the south-eastern provinces
of the Netherlands [1,2]. The main transmission route is
through inhalation of contaminated aerosols. Climatic
conditions play a role as dry and windy conditions are
favourable for transmission of the bacterium [3]. C. bur-
netii is very resistant to heat, drought and disinfectants
[4]. Domestic ruminants are the primary animal reser-
voirs for C. burnetii for human infections. In addition,
outbreaks due to parturient cats and dogs are described
[5,6]. When infected animals give birth, large numbers
of C. burnetii can be shed, but shedding of the bacter-
ium can also occur via urine, faeces and milk, and is dif-
ferent between ruminant species in duration and
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usually asymptomatic in cattle, while in dairy goats and
dairy sheep an infection may result in abortion or still-
birth [4], often without preceding symptoms. Q fever
affected goat herds can show abortion rates up to 90%
[8,9].
Dairy goats are considered the predominant source of
the community Q fever epidemics in the Netherlands
s i n c e2 0 0 7[ 2 , 1 0 ] .T h eo v e r a l lg o a td e n s i t yi nt h eN e t h -
erlands is 38 goats per square kilometre and the total
number of goats has increased six-fold from 61.000 in
1990 up to 374.000 in 2009. In the period 2000 until
2009, dairy goat farming has increased almost 3-fold
from 98.000 up to 274.000 dairy goats and is especially
concentrated in the southern parts of the Netherlands
[ 1 1 ] .I nt h eN e t h e r l a n d s ,d a i r yg o a t sa r em a i n l yk e p t
year-round in deep litter houses, with partially open
walls or roofs. During 2005-2009, Q fever abortion
waves were reported on 28 dairy goat farms and 2 dairy
sheep farms with abortion percentages varying between
10 and 60% [12]. Human incidence of acute Q fever was
highest each spring (April-June), following the main
lambing season (December-April) [2]. In order to reduce
t h er i s ko fe x p o s u r ef r o mC. burnetii-infected small
ruminants to humans, mandatory vaccination started in
the epicentre of the human outbreak in the southeast of
the Netherlands from April 2009 onwards following a
voluntary small ruminant vaccination campaign in a
more restricted area in the fall of 2008. The 2009 vacci-
nation campaign targeted all dairy goat and dairy sheep
farms with at least 50 animals, all open farms (petting
zoos, care farms) and all known clinically infected farms
since 2005. Studies evaluating the effect of vaccination
are promising, especially in nulliparous animals [13]. In
October 2009, mandatory bulk milk monitoring using
PCR was implemented on all dairy goat and dairy sheep
farms with more than 50 animals, to actively detect C.
burnetii-positive farms, next to the mandatory notifica-
tion of abortion waves [2]. As of 25 April 2011, 96 dairy
goat farms (about 25% of the about 360 large dairy
goats farms in 2010) and 2 dairy sheep farms (5%) were
found to be bulk milk-positive [14]. In European coun-
tries where studies have been done, the seroprevalence
in goats in general varies between 6.5% and 48.2%, but
is reported up to 75% if sampling is done in shedder
g o a t ss u c ha sr e p o r t e di nF r a n c e[ 1 5 , 1 6 ] .F a r mp r e v a -
lences were 42.9% in Northern Ireland, 43.0% in a study
from Italy and 47.0% in northern Spain [17-19]. Sero-
prevalences may vary widely within countries as demon-
strated in the south-east of France, where at 39 farms
without Q fever abortions during the last five years
within-herd rates ranged from 0-98% [20]. In 2008, in
the Netherlands, the overall Q fever seroprevalence in a
convenience sample of 3,134 samples from 442 goat
farms submitted for the Brucella melitensis monitoring
program was 7.8% (95%CI 6.9-8.8%) [12]. The seropre-
valence was 11.4% in the southeastern part of the Neth-
erlands compared to 5.3% in the rest of the country.
Seroprevalence was higher among the 1,290 dairy goats
compared to the 1,844 non-dairy goats (14.7%, 95% CI
2.8%-16.6% versus 3.0%, 95%CI 2.2%-3.8%). The farm
prevalence (at least one goat testing positive), was 17.9%
(95%CI 14.2-21.5). The average within-herd prevalence
on a positive dairy goat farm was 32.1% (95%CI 28.4-
35.9%) (van den Brom R, Moll L, Vellema P: Q fever
seroprevalence in sheep and goats in the Netherlands in
2008, submitted). Risk factor studies for Q fever in dairy
goat farms in the Netherlands have not been done. The
aim of this study was to assess the actual magnitude of
the spread of C. burnetii among small ruminants follow-
ing the (what turned out to be the peak-) epidemic sea-
s o ni nh u m a n si n2 0 0 9 ,t h r o u g ht e s t i n go fs e r af r o ma
nationwide representative sample of dairy goat farms
prior to the start of mandatory vaccination. We identi-
fied risk factors for Q fever seropositivity on farm and
animal level in order to update control measures and to
provide targeted advice for the Dutch dairy goat sector.
Methods
Study design and sampling strategy
The study was designed as a cross-sectional study. In
March 2009, 357 dairy goat farms with more than 100
dairy goats were present in the Netherlands and
approached for participation. These farms are consid-
ered commercial farms and include the size of all
known clinically infected goat farms with Q fever. The
wide range in herd size allows studying the influence of
this size on the infection risk. For all farms, results from
bulk milk monitoring using PCR were available from
October 2009 until October 2010. Farms with less than
100 goats and farms with a goat population completely
vaccinated during the voluntary vaccination campaign in
2008 (approximately 36,000 goats) were excluded. To
estimate farm prevalence, 110 farms should be included
based on an expected prevalence of 50%, with 95% con-
fidence, 10% accuracy and 90% sensitivity of the serolo-
gical test used [21]. Based on an assumed within-herd
prevalence of 16% [16,19] and a herd size varying
between 100 and 4000 goats, 21 goats per farm were to
be screened for C. burnetii infection. On participating
farms, the private veterinary practitioner collected sero-
logical samples from the jugular vein of goats before the
vaccination campaign in 2009 started. Written informed
consent was obtained from each participating farm. As
the investigation by the Animal Health Service of goat
serum samples taken by the private veterinary practi-
tioner could be considered as part of regular and rou-
tine clinical-diagnostic care, no official review and
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needed.
Samples were collected in the mandatory vaccination
area of 2009 between May and September 2009 (91% of
samples were taken in May and June 2009) while sam-
ples outside this area were collected between July 2009
and May 2010 (81% of samples were taken from Octo-
ber 2009 until January 2010). A farm questionnaire was
sent by e-mail or regular mail to all participating farms
between October 2009 and May 2010 and completed by
the farm owner or farm manager. The questionnaire
addressed the general farm situation, number of lambs
and goats, housing characteristics, vermin control and
manure handling in 2008 (the year before the manda-
tory hygiene protocol was implemented), general health
status and reproductive problems (including abortion
rates) of the herd, breeding information, annual milk
production and farm management, including biosecurity
and hygiene measures for own staff and farm visitors.
Laboratory analysis
Individual goat serum samples were tested with an
ELISA test (Ruminant serum Q Fever ELISA kit, Labor-
atoire Service International, Lissieu, France) on C. bur-
netii specific antibodies with a single 1:400 serum
dilution. All steps were carried out according to the
instruction of the manufacturer. A goat was considered
ELISA-positive if the optical density percent was 40 or
higher, otherwise negative. A farm was considered posi-
tive if at least one goat on the farm was classified
positive.
Data analyses
Non-response analysis
Participating and non-participating farms were com-
pared with respect to bulk milk PCR results (LSI TaqVet
Coxiella burnetii, LSI, Lissieu, France), herd size, goat,
sheep and cattle density, degree of urbanization and
region where farms were located to study the represen-
tativeness of participating farms. Categorical variables
among participating and non-participating farms were
compared with a chi-square or Fisher exact test while
numerical variables were compared using the Wilcoxon
rank sum test.
Descriptive statistics and risk factor analysis
Animal and farm prevalence of C. burnetii with corre-
sponding exact 95 percent confidence intervals were cal-
culated. First, frequency tables of categorical variables
were analysed and distributions of continuous variables
were studied, and if not linearly related to the outcome
variable divided into classes based on biological argu-
ments, and if these were lacking based on medians.
Potential risk factors on farm level were analysed by
logistic regression (PROC LOGISTIC, SAS Institute Inc.,
2004), and on animal level by generalized linear regres-
sion analysis accounting for farm effect (PROC GEN-
MOD, SAS Institute Inc., 2004). For the latter, an
exchangeable correlation covariance structure fitted best
and was used to account for within-herd variation. First,
univariable analyses were performed. In multivariable
analysis, all variables with a p-value below 0.20 in the
univariable analyses were included. For multivariable
analysis on farm level, we excluded variables with less
than 10% of data in one risk category. Proxy outcomes
such as bulk milk status and mandatory vaccination area
were not included in multivariable analyses. A back-
wards elimination procedure was performed until all
variables were significant at 10% significance level in the
likelihood ratio test. Two-way interactions between bio-
logical plausible and significant variables in the multi-
variate model were investigated. For the final model on
farm level, model fit was assessed with the Hosmer-
Lemeshow-Goodness-of-fit test (Hosmer and Lemeshow,
1989). Model fit on animal level was assessed by the
QIC (Quasilikelihood under the Independence Model
Criterion) goodness of fit statistic for GEE models.
Results
Non-response analysis
Of the 357 approached farms, 23 farms were excluded
as they were not eligible for participation due to com-
plete vaccination in 2008 or a herd size < 100 goats. In
total, 123 dairy goat farms (36.8%) out of 334 eligible
farms were willing to cooperate (Figure 1). Three addi-
tional dairy goat farms (0.9%) with only three goat sera
were excluded from analysis and considered as a non-
participant. Farms in the mandatory vaccination area
participated more often than farms outside this area,
46.1% versus 30.1% (p < 0.05). The median number of
goats among participating farms was 782 goats com-
pared to 689 goats in the non-participating farms (p <
0.05). Bulk milk PCR-positivity did not differ between
participating and non-participating farms, 24.4% and
22.8%, respectively. Participating and non-participating
farms were also comparable with regard to location in
rural areas (95.1% versus 97.2%), municipal cattle den-
sity (median: 121 versus 117), sheep density within 10
kilometres from farm (median: 21 versus 16) and affilia-
tion to an organic goat farming cooperative (11.4% ver-
sus 13.4%).
Descriptive results
From the 123 participating farms, 51 farms (41.5%) were
located in the two southern provinces, 44 (35.8%) in the
eastern part, 16 (13.0%) in the western part and 12
(9.7%) in the northern part of the country. The majority
of farms (95.8%) were located in rural areas (< 500
addresses/km
2). A farm questionnaire was available for
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the investigation of risk factors was conducted in this
subsample of 96 farms. Participating goat farms
started between 1975 and 2009 (median: 1997, inter-
quartile range (IQR) 1995-2000). The Dutch White
goat was present on all farms. Additionally, other
goat species, such as Toggenburger, Dutch pied origi-
nal, Anglo-Nubian, alpine or mixed breeds were pre-
sent at 50 farms (52.1%). The median annual milk
production per goat was 1000 litres (IQR 900-1150
litres). Fourteen farms (14.6%) reported abortion per-
centages of 4% or higher in the period 2007-2009 (n
= 11) and/or experienced an abortion wave due to Q
fever since 2005 (n = 7).
Seroprevalence
A total of 2,828 serum samples were taken at the 123
participating farms. At 101 farms (82.1%), 21 samples
per farm were taken as planned, while at the other 22
farms the median number of samples was 22 (range 13-
116). Of these 2,828 samples, 21.4% were seropositive
(exact 95% CI: 19.9-23.0) (Figure 2). At least one posi-
tive goat serum sample was found on 53 out of the 123
farms (43.1%; exact 95% CI: 34.2-52.3). On these 53
positive farms 46.6% of tested animals were seropositive
(exact 95% CI: 43.9-49.3%). The prevalence of seroposi-
tive goats per farm varied between 4.8% and 95.2%
(mean 46.0%, median 45.8% positive goats per farm,
inter-quartile range 23.8%-63.6%). The average herd size
on positive farms was 1,116 goats (median 890 goats,
range 121-4,146) while the average herd size of negative
farms was 793 goats (median 729 goats, range 120-
2,970). Within the mandatory vaccination area, 58.5% of
farms were classified positive compared to 25.9% of goat
farms outside this area. Samples within the mandatory
vaccination area were almost all taken during the end of
the lambing season in 2009 (May-June) while 82.9% of
s a m p l e so u t s i d et h i sa r e aw e r et a k e nd u r i n gt h en e x t
lambing season in 2010 defined as December 2009 until
May 2010. Median age, known for 1,474 goats, was 2.3
years. Seroprevalence increased with age: 5.8% for goats
younger than 1 year, 15.7% between 1-3 years and 26.1%
older than 3 years. Prevalence of the group that had
lambed at least once was significantly higher than in the
nulliparous group (19.4% (n = 1,251) vs. 11.9% (n =
236); for 1,341 goats lambing status was unknown.
Comparison of bulk milk and serological status
From the 123 participating farms, 30 were bulk milk
PCR positive (24.4%; exact 95% CI: 17.1-33.0). Among
these 30 farms, 28 (93.3%) were also classified positive
based on individual animal sera, with an average animal
prevalence of 54.4% per positive farm. One farm was
serologically negative in May 2009, but tested bulk milk-
positive in November 2009, while the other farm was
serologically negative in January 2010, and tested bulk
milk-positive end March 2010. At 25 (26.9%) of the 93
bulk milk-negative farms at least one goat was positive,
Figure 1 Study participation of invited commercial dairy goat farms (> 100 goats), The Netherlands, 2009-2010.
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Page 4 of 14Figure 2 Serological status of participating farms and bulk milk PCR status of eligible dairy goat farms. Map of the Netherlands showing
the 12 provinces, the mandatory vaccination area 2009 and the geographic locations of 123 participating dairy goat farms (median 782 goats,
range 120-4146) and 211 non-participating farms (median 689 goats, range 105-4733), the serological and bulk milk PCR status of participating
farms and bulk milk PCR status only of non-participating farms
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farm.
Univariable analyses on farm level
Risk factors associated (p < 0.20) with farm seropositiv-
ity were herd size larger than 800 goats, location in
mandatory vaccination area, farm location within 8 km
from nearest bulk milk PCR-positive farm, high goat
and cattle density, 3 or more stables, use of artificial
insemination, having a dog at the farm, having a dog or
a cat in the goat stable, unknown status of signs of ver-
min in roughage or litter, use of silage feed, maize and
other feed such as lucerne or pulp, straw imported from
abroad or unknown origin, use of a fodder mixer, con-
trolling nuisance animals (e.g. wild birds) by covering air
spaces, abortion percentage ≥ 4% during 2007-2009 or
known history of abortion wave due to Q fever since
2005, spread of manure to other places than own farm
or direct environment, two or more lambing seasons
annually and having a closed or open tenure versus a
semi-closed tenure (e.g. only bucks supplied). Protective
factors were keeping rabbit(s) or pet birds, sidewall ven-
tilation, and goat supply from the provinces of Friesland
and Overijssel (Table 1).
Multivariable analysis on farm level
A total of 21 variables were included in the initial multi-
variable model. Artificial insemination strongly corre-
lated with large herd size and was excluded from the
model. Supply from the provinces of Friesland and
Overijssel provinces was not included in the model as
possible protective factor because overall goat supply or
supply from other provinces were not significant risk
factors in the univariable analysis. Having a rabbit or a
p e tb i r dw a sa l s on o ti n c l u d e da si tc o r r e l a t e di n v e r s e l y
with having a dog. The following nine variables
remained independently associated with seropositivity in
the final model (Table 2): farm located within 8 km
proximity to a bulk milk PCR-positive dairy goat farm,
high cattle density, controlling nuisance animals by cov-
ering air spaces, presence of cats and/or dogs in the
goat stable, straw imported from abroad or unknown
origin, a herd size of 800 goats or more and unknown
status of signs of vermin in roughage or litter. Interac-
tion terms were not statisticially significant and did not
improve the model. The Hosmer and Lemeshow Good-
n e s s - o f - F i tt e s ts h o w e dn ol a c ko ff i to ft h em o d e l( P=
0.60).
Univariable risk factor analyses on animal level
The same variables as in the analysis on farm level were
identified on animal level, except for having a dog in the
stable and straw imported from abroad or unknown ori-
gin. Additionally the following univariable risk factors
were identified on animal level: mechanic ventilation in
the stable, use of windbreak curtain only or in combina-
tion with wind shields, presence of few nuisance animals
(e.g. wild birds), while additional univariable protective
factors on animal level were presence of the Anglo-
Nubian goat and keeping laying hens (Table 3).
Multivariable risk factors analysis on animal level
T h ev a r i a b l ep r e s e n c eo fad o go nt h ef a r mw a sn o t
included on animal level, as the reference category was
too small as almost all farms (88%) had a dog. Seven
variables remained in the multivariable model on animal
level of which five also were present in the final model
on farm level i.e. farm located within 8 km proximity
from a bulk milk PCR-positive dairy goat farm, high cat-
tle density, presence of a cat in the goat stable, control-
ling nuisance animals by covering air spaces and
unknown status of vermin in roughage or litter. Addi-
tional risk factors on animal level were use of artificial
insemination and use of windbreak curtain only or in
combination with wind shields compared to none of
these (Table 4). Within-farm variation accounted for
34.6% of all non-explained variance of the model.
Discussion
The overall animal and farm seroprevalence of C. burne-
tii in dairy goats farms with ≥ 100 dairy goats observed
in this study was 21.4% and 43.1% respectively. These
seroprevalence estimates increased compared to the ser-
oprevalence measured in 2008, when 14.7% of individual
dairy goats were serologically positive and 17.9% of
farms tested positive. The within-herd prevalence on
positive dairy goat farms in our study was 46.6% com-
pared to 32.1% (95%CI 28.4%-35.9%) in 2008 (van den
Brom R, Moll L, Vellema P: Q fever seroprevalence in
sheep and goats in the Netherlands in 2008, submitted).
This study demonstrates substantial transmission of C.
burnetii within and between dairy goat farms in recent
years prior to the mandatory vaccination campaign in
the Netherlands.
The relatively low overall participation rate of 37%
probably reflects the reluctance to take part in the study
at the same time as control measures increased, includ-
ing finally the culling of pregnant goats at bulk milk
PCR-positive farms. The overrepresentation of farms
located in the mandatory vaccination area probably
reflects that the risk perception of the farmers played a
role. Because of the higher participation rate in this
area, we might have overestimated the overall seropreva-
lence in eligible dairy goat farms in the Netherlands. As
expected, dairy goat farms located in the mandatory vac-
cination area were more often seropositive in our study,
as was previously observed in 2008 (van den Brom R,
Moll L, Vellema P: Q fever seroprevalence in sheep and
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level
Variable Category N (%) Prev(%) OR 95% CI P-value
Herd size
(number of goats according to UBN registry)
≥ 800 47 (49.0) 59.6 3.7 1.6-8.6 0.0020
< 800 49 (51.0) 28.6 Ref
Mandatory vaccination area 2009 Inside 53 (55.2) 58.5 4.1 1.7-9.9 0.0010
Outside 43 (44.8) 25.6 Ref
Goat density per km
2
within 5 km radius from farm
≥ 25 48 (50.0) 56.3 2.8 1.2-6.5 0.0130
< 25 48 (50.0) 31.3 Ref
Cattle density per km
2
in farm municipality (excl. meat calves)
≥ 100 67 (69.8) 50.8 2.7 1.1-7.0 0.0329
< 100 29 (30.2) 27.6 Ref
Distance to nearest bulk milk PCR-positive farm
(km)
0- < 4 29 (30.2) 72.4 10.0 3.4-29.1 < .0001
4- < 8 19 (19.8) 57.9 5.2 1.7-16.5
≥ 8 48 (50.0) 20.8 Ref
Number of stables 1-2 stables 40 (41.7) 35.0 Ref 0.1424
≥ 3 stables 56 (58.3) 50.0 1.9 0.8-4.3
Use of artificial insemination Yes 26 (27.1) 61.5 2.7 1.1-6.7 0.0370
No 70 (72.9) 37.7 Ref
Having at least one dog at the farm Yes 84 (87.5) 47.6 4.6 0.9-22.0 0.0337
No 12 (12.5) 16.7 Ref
Having at least one rabbit at the farm Yes 26 (27.1) 30.8 0.5 0.2-1.2 0.1138
No 70 (72.9) 48.6 Ref
Having at least one pet bird at the farm Yes 25 (25.0) 28.0 0.4 0.2-1.1 0.0606
No 71 (75.0) 49.3 Ref
Dog(s) in goat stable Yes 60 (62.5) 51.7 2.4 1.0-5.8 0.0415
No/unknown 36 (37.5) 30.6 Ref
Cat(s) in goat stable Yes 34 (35.4) 58.8 2.6 1.1-6.1 0.0275
No/unknown 62 (64.6) 35.5 Ref
Signs of vermin (mice, rats, birds)
in roughage or litter during past 12 months
Unknown 14 (14.6) 64.3 2.7 0.8-8.7 0.0944
Known (yes or no) 82 (85.4) 40.2 Ref
Feeding silage Yes 64 (66.7) 51.6 2.7 1.1-6.8 0.0269
No 32 (33.3) 28.1 Ref
Feeding maize Yes 40 (41.7) 55.0 2.2 1.0-5.0 0.0602
No 56 (58.3) 35.7 Ref
Use of lucerne, pulp feed
or other roughage/litter
Yes 24 (25.0) 58.3 2.2 0.9-5.6 0.0972
No 72 (75.0) 38.9 Ref
Origin of straw Abroad/unknown 59 (61.5) 49.2 1.8 0.8-4.2 0.1757
No straw or domestic straw 37 (38.5) 35.1 Ref
Feeding method Hand/wheelbarrow 31 (32.3) 22.6 Ref 0.0202
Fodder mixer 56 (58.3) 57.1 4.6 1.7-12.4
Automatic 9 (9.4) 33.3 1.7 0.3-8.7
Sidewall ventilation Yes 38 (39.6) 34.2 0.5 0.2-1.2 0.1252
No 58 (60.4) 50.0 Ref
Control nuisance animals
(e.g. wild birds) in 2008
Yes, by covering air spaces 15 (15.6) 73.3 2.1 1.3-15.4 0.0409
Yes, only via another ways
(a.o. capture cage)
13 (13.5) 38.5 1.0 0.3-3.4
Not applicable 68 (70.8) 38.2 Ref
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trast, the estimated seroprevalence might have been
underestimated as the non-eligible farms probably over-
represented positive farms, such as farms with a clinical
history of Q fever. These were prioritized for vaccina-
tion early 2009, and probably positive and suspected
farms relatively more often volunteered for vaccination
in the 2008 campaign. Nevertheless, the net effect of
these biases are thought to be limited, as bulk milk-posi-
tive farms were equally represented among participating
and non-participating farms. As the diversity in farms,
also outside the vaccination area, was still large, effect
on the risk factor analyses is considered limited and
results are considered generalizable to all commercial
dairy goat farms in the Netherlands.
Small ruminant studies have shown that goats test sig-
nificantly more often serologically positive during preg-
nancy and in the periparturient period compared to
early pregnancy or non-pregnant period (van den Brom
R, Moll L, Vellema P: Q fevers e r o p r e v a l a n c ei ns h e e p
and goats in the Netherlands in 2008, submitted), [21].
Different sampling periods in our study, mainly at the
Table 1 Univariable logistic regression of farm-based factors associated with serological Q fever infection on farm
level (Continued)
Percentage of aborting goats or goats with stillbirth
in 2007-2009 or known history of abortion wave
due to Q fever since 2005
< 4% 82 (85.4) 39.0 Ref 0.0234
≥ 4% and/or abortion wave 14 (14.6) 71.4 3.9 1.1-13.5
Spread of manure On or near own farmland 79 (82.3) 39.2 Ref 0.0497
To other places 15 (15.6) 66.7 3.1 1.0-9.9
Lambing periods in 2009 ≤ 1 57 (59.4) 31.6 Ref 0.0035
≥ 2 39 (40.6) 61.5 3.5 1.5-8.1
Type of tenure Completely closed 27 (28.1) 55.6 2.4 0.9-6.1 0.1158
Closed for female goats only 52 (54.2) 34.6 Ref
No, not closed 16 (16.7) 56.3 2.4 0.8-7.6
Goat supply from the province of Friesland Yes 19 (19.6) 26.3 0.4 0.1-1.2 0.0806
No 77 (80.2) 48.1 Ref
Goat supply from the province of Overijssel Yes 10 (10.4) 20.0 0.3 0.1-1.4 0.0961
No 86 (89.6) 46.5 Ref
Frequency (N), prevalence (Prev), odds ratio (OR), and 95% confidence interval (95%CI) of variables with Likelihood ratio test P values < 0.20 (96 farms, 43.1%
positive farms based on total sample of 123 farms and 2,828 goats)
Table 2 Multivariable logistic regression of farm-based factors associated with serological Q fever infection on farm
level
Variable Category N (%) Prev (%) aOR 95% CI
Distance to the nearest bulk milk PCR-positive farm (km) < 8 48 50.0 66.7 12.9 3.0-54.8
≥ 8 48 50.0 20.8 Ref
Cattle density per km
2 in farm municipality (excl. meat calves) ≥ 100 67 69.8 50.8 14.4 2.7-78.4
< 100 29 30.2 27.6 Ref
Herd size (number of goats according to UBN registry) ≥ 800 47 49.0 59.6 2.8 0.8-9.4
< 800 49 51.0 28.6 Ref
Control nuisance animals (e.g. wild birds) in 2008 Yes, by covering air spaces 15 84.4 73.3 48.8 4.0-
591.2
By other ways or not applicable 81 15.6 38.3 Ref
Dogs(s) in goat stable Yes 60 62.5 51.7 3.8 1.0-14.2
No/unknown 36 37.5 30.6 Ref
Cat(s) in goat stable Yes 34 35.4 58.8 6.3 1.5-25.8
No/unknown 62 64.6 35.5 Ref
Origin of Straw Abroad/unknown 59 61.5 49.2 5.0 1.3-19.6
No straw or domestic straw 37 38.5 35.1 Ref
Signs of vermin (mice, rats, birds) in roughage or litter during past 12 months Unknown 14 14.6 64.3 4.3 0.8-22.3
Known (yes or no) 82 85.4 40.2 Ref
Factors associated with Q fever on farm level with their frequency (N), prevalence (Prev), adjusted odds ratio (aOR) with corresponding 95% confidence interval
(95% CI) in the final multivariable logistic model (96 farms; 43.1% positive farms based on total sample of 123 farms and 2,828 goats)
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Page 8 of 14Table 3 Univariable logistic regression of farm-based factors associated with serological Q fever infection on animal
level
Variable Category N Prev.
(%)
OR 95%
CI
P-
value
Herd size (according to UBN registry) < 800 1164 13.8 Ref 0.0017
≥ 800 1013 30.2 3.3 1.6-7.0
Mandatory vaccination area Inside 1116 28.2 3.3 1.5-7.3 0.0042
Outside 1061 14.3 Ref
Goat density per km
2 in 5 km radius from the farm < 25 1167 18.2 Ref 0.0805
≥ 25 1010 25.3 1.9 0.9-3.9
Cattle density per km
2 in farm municipality (excl. meat calves) < 100 643 11.2 Ref 0.0084
≥ 100 1534 25.8 3.5 1.4-8.9
Distance to nearest bulk milk PCR-positive farm (km) 0- < 4 688 37.8 5.0 2.2-
11.6
<
.0001
4- < 8 400 25.3 3.2 1.1-8.9
≥ 8 1089 9.7 Ref
Anglo-Nubian goat Present 402 11.9 0.5 0.2-1.1 0.0694
Absent 1775 23.6 Ref
Number of stables 1-2 stables 983 14.2 Ref 0.0046
≥ 3 stables 1194 27.4 3.0 1.4-6.5
Use of artificial insemination Yes 572 34.6 2.7 1.3-5.6 0.0181
No 1585 17.0 Ref
Presence of laying hens at the farm Yes 359 8.9 0.3 0.1-0.9 0.0184
No 1818 23.9 Ref
Having at least one dog at the farm Yes 1927 23.5 Ref 0.0530
No 250 5.6 0.2 0.0-1.0
Having at least one rabbit at the farm Yes 608 6.4 0.2 0.1-0.6 0.0008
No 1569 27.3 Ref
Having at least one pet bird at the farm Yes 501 9.4 0.3 0.1-0.9 0.0132
No 1676 25.1 Ref
Cat(s) in goat stable Yes 786 24.2 1.7 0.8-3.4 0.1718
No/unknown 1391 19.9 Ref
Signs of vermin (mice, rats, birds) in roughage or litter during past 12
months
Unknown 364 41.8 2.8 1.2-6.2 0.0471
Yes or No 1813 17.4 Ref
Feeding silage Yes 1498 26.1 Ref 0.0218
No 679 11.2 0.4 0.2-0.9
Feeding maize Yes 872 28.8 Ref 0.0333
No 1305 16.6 0.5 0.2-0.9
Use of lucerne, pulp feed or other roughage/litter Yes 505 28.1 1.8 0.9-3.7 0.1445
No 1672 19.4 Ref
Feeding method With hand/wheelbarrow 772 13.5 0.3 0.1-0.9 0.0299
With fodder mixer 1191 27.0 Ref
Automatic 214 19.6 0.5 0.1-1.9
Type of ventilation system of stables Mechanic ventilation 593 30.5 2.0 1.0-4.3 0.0899
No mechanic ventilation 1584 18.1 Ref
Use of windbreak curtain and/or windshields Windbreak curtain 799 30.5 3.7 1.5-9.3 0.0198
Only wind shields 937 18.8 1.6 0.6-4.3
None 441 10.7 Ref
Presence of nuisance animals (e.g. wild birds) in the stable Yes, many 388 12.6 0.6 0.2-2.0 0.1206
Yes, few 880 27.3 1.7 0.8-3.7
No 889 20.0 Ref
Combat of nuisance animals (e.g. wild birds) in 2008 Via covering air spaces 349 38.7 3.0 1.4-6.3 0.0721
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Page 9 of 14end of the lambing season in 2009 inside the vaccination
area and in the beginning of the lambing season 2010
outside the vaccination area, make it difficult to disen-
tangle the possible effect of seasonal sampling on the
observed significant regional differences. We think this
s t u d ys h o w sat r u eh i g h e rs e r o p r e v a l e n c ei nt h e
mandatory vaccination area as it (1) confirms the signifi-
cant difference already observed in 2008 in the south-
eastern part of the country and (2) reflects the major
burden of human and veterinary clinical Q fever cases
that occurred in the south-eastern part of the country
[1,2,10]. A distinction with ELISA between IgG phase 1
Table 3 Univariable logistic regression of farm-based factors associated with serological Q fever infection on animal
level (Continued)
Yes, only via other ways (e.g. capture
cage)
274 21.2 1.3 0.4-4.3
Not applicable 1554 17.6 Ref
Spread of manure To other places/not applicable 352 30.7 2.1 1.0-4.7 0.1076
On farmland or near environment 1825 19.7 Ref
Lambing periods in 2009 ≤ 1 1351 15.6 Ref 0.0039
> 1 826 31.0 3.0 1.5-6.1
Percentage of aborting goats or goats with stillbirth in 2007-2009
or known history of abortion wave due to Q fever since 2005
< 4% 1882 18.4 Ref 0.0251
≥ 4% 295 40.7 3.4 1.5-7.6
Type of Tenure Completely closed 590 29.5 2.3 1.0-5.0 0.0898
Only closed for female goats 1217 16.1 Ref
Not closed 349 27.8 2.2 0.8-5.6
Provinces where supplied animals originated Provinces of Friesland and/or
Overijssel
639 8.0 0.3 0.1-0.7 0.0028
Supply from other provinces or no
supply
1538 27.1 Ref
Factors associated with Q fever with their frequency (N), animal prevalence (Prev), odds ratio (OR), and 95% confidence intervals (95% CI) with P value of the
univariable generalized linear regression < 0.20 on animal level accounting for random herd effect (2,177 animals from 96 farms; 21.4% seropositive animals and
43.1% positive farms based on total sample of 123 farms and 2,828 goats)
Table 4 Multivariable logistic regression of farm-based factors associated with serological Q fever infection on animal
level
Variable Category N (%) Prev
(%)
aOR 95%
CI
Distance to the nearest bulk milk PCR-positive farm (km) < 8 km 1088 50.0 33.2 3.2 1.4-7.3
≥ 8 km 1089 50.0 9.73 Ref
Cattle density per km
2 in farm municipality (excl meat calves) < 100 643 29.5 11.2 Ref
≥ 100 1534 70.5 25.8 4.5 2.0-9.9
Combat of nuisance animals (e.g. wild birds) in 2008 Yes, by covering air spaces 349 16.0 38.7 3.7 1.8-7.9
By other ways or not
applicable
1828 84.0 18.2 Ref
Signs of vermin (mice, rats, birds) in roughage or litter during past 12
months
Unknown 364 16.7 41.8 3.3 1.4-7.9
Known (yes or no) 1813 83.3 17.4 Ref
Cat(s) in goat stable Yes 786 36.1 24.2 2.6 1.2-5.6
No/unknown 1391 63.9 19.9 Ref
Use of windbreak curtain and/or windshields Windbreak curtain 799 36.7 30.5 2.8 1.2-6.7
Only wind shields 937 43.0 18.8 1.7 0.7-4.1
None 441 4.9 10.6 Ref
Artificial insemination Yes 572 26.3 34.6 2.3 1.2-4.7
No 1585 72.8 17.0
Factors associated with Q fever with their frequency (N), animal prevalence (Prev), adjusted odds ratio (aOR) with corresponding 95% confidence interval (95%
CI) in the final multivariable model on animal level with random herd effect (2,177 animals from 96 farms; 21.4% positive animals; 43.1% positive farms based on
total sample of 123 farms and 2,828 goats)
**within-farm variation accounts for 34.6% of non-explained variance
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Page 10 of 14and 2 antibodies might have helped to distinguish more
recent infection and older infections in animals to assess
such a sampling effect [22].
Seroprevalence of C. burnetii in goats has been stu-
died in several countries [16]. Comparison should be
done with caution as study populations and study years
vary and different serological assays with different per-
formance are used [23,24]. The goat seroprevalence was
8.8% in Albania [25] and 6.5% in Northern Greece [26].
In Spain, the goat and farm prevalence was 8.7% and
45%, respectively, based on ELISA [19] similar to results
of a smaller study from Northern Ireland (goat seropre-
valence 9.3%, farm prevalence 42.9%) [17], and in Sardi-
nia in 1999-2002: goat prevalence 13% and farm
prevalence 47% using an alternative criterion of two or
more seropositive animals per farm [18]. In our study,
the farm seroprevalence was 38.2% (95%CI 29.6%-46.8%)
using the same criterion, so only slightly lower than
with at least one positive goat as criterion for a positive
farm. Clearly different goat prevalences were observed
in Poland, with the absence of C. burnetii IgG phase 2
antibodies in 918 goats from 48 herds [27] while high
estimates were observed in Cyprus (48.2% in 420 ran-
dom goats) [28] and in Gran Canaria island, Spain
(60.4% in 733 goats) [29]. Ignoring these last exceptions,
the overall goat prevalence of 21.4% observed in our
study was relatively high compared to other European
seroprevalence studies (6.5%-13%), while the farm preva-
lence falls within the range of farm prevalences (43-47%)
in other European countries. The within-herd preva-
lence of 46.6% among the positive farms indicates strong
circulation of the bacterium within the herds, suggesting
farm conditions or practices favoring spread, such as a
relatively large number of goats per farm, year-round
housing in deep litter stables or reflects circulation of a
unique efficiently spreading strain. In France, goat herds
with a within-herd prevalence over 40% had the highest
proportion of shedder goats and highest averages of
shedding quantities as determined by real-time qPCR on
vaginal swabs, representing a high risk level for environ-
mental contamination and by that transmission within
farms [20]. At about one quarter of the bulk milk PCR-
negative farms, on average 37% of the goats tested sero-
positive. This might be explained by the fact that not all
seropositive goats shed the bacterium in milk and that
excretion of the bacterium is intermittently [7,15].
Besides, antibodies persist in goats [9], finding still posi-
tive serology but no actual excretion of DNA which is
measured in the bulk milk monitoring program.
Considering the risk factors analyses, the exposure
information collected in the farm questionnaire is not
necessarily related to the relevant time period for sero-
conversion as we do not know at what moment the
actual infection with C. burnetii occurred in
serologically positive goats. However, since the median
age of tested goats was 2.3 years, and infections espe-
cially occur during the first pregnancy of nulliparous
goats (between 1-2 years of age) it is plausible that
infection in the majority of goats occurred during the
periods covered in the questionnaire. It is most likely
that goats on these farms get infected the same way as
h u m a n s ,i . e .b yi n h a l a t i o no fC. burnetii infected aero-
sols [4], as indicated by the increased risk of a farm
location within 8 km of a bulk milk-positive small rumi-
n a n tf a r m .F r o ml i t e r a t u r ew ek n o wt h a th e r ds i z ea n d
high farm and animal densities can augment the risk for
acquisition of (respiratory) zoonoses, for example in
swine diseases and avian influenza in poultry [30,31]. In
our study, we found that farms with more than 800
goats had a higher risk to be positive than smaller
farms. This corresponds with Rupanner et al. who
observed in the 1970s an increased infection risk of
goats with C. burnetii with increasing herd size [32].
Similar associations with herd size were found for Q
fever in dairy cattle [17,33]. This can be explained by a
larger population at risk, an increased risk of introduc-
tion and transmission of pathogens within and between
herds for instance by larger amounts of feed, animal
supply and more professionals working at or visiting the
farm. In addition, farm management practices or envir-
onmental characteristics related to large farms but not
c o v e r e di no u rq u e s t i o n n a i r em i g h tp l a yar o l ei nt h e
observed increased risk. As about 35% of the unex-
plained variance in the model was explained by the
farm-effect, relevant underlying factors might have been
missed. Therefore, an advice to limit the herd size with-
out further changes in farm management does not
necessarily guarantee a reduction in infection risk. Arti-
ficial insemination was an independent risk factor at
animal level and found to be related to farms with a
herd size over 800 goats. Artificial insemination can
therefore be an indirect marker of farm management
practices in larger farms that were not covered in the
questionnaire. From cattle studies, it is known that
viable C. burnetii is detected in semen of seropositive
bulls indicating the possibility of sexual transmission
[34]. Between 3000 and 4000 inseminations each year
are carried out by the main goat artificial insemination
(AI) cooperative using fresh semen from the Nether-
lands and frozen semen from French or Dutch origin.
Since end of 2008, AI bucks are routinely screened for
presence of C. burnetii. In a targeted survey, so far, goat
semen samples from 300 bucks present on bulk milk-
positive farms were all negative (personal communica-
tion, P. Vellema, Animal Health Service). High cattle
density in the municipality where the farm was located
was also an independent risk factor, indicating the pre-
s e n c eo fo n eo rs e v e r a lc a t t l ef a r m si nt h es a m e
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Page 11 of 14municipality as the goat farm. A recent review on C.
burnetii infection in domestic ruminants suggested a
higher seroprevalence in cattle compared to goats and
sheep [16]. In the Netherlands, a prevalence of bacterial
DNA of 56.6% in cattle bulk tank milk was found as
compared to 24.4% bacterial DNA in goat bulk tank
milk among participating farms in our study, confirming
widespread circulation of the bacterium among cattle
[35]. However, an association with cattle density was
not observed when the outcome variable ‘bulk milk
PCR-positivity’ was used instead of ELISA-seropositivity
(data not shown). Therefore, it is hypothesized that cat-
tle especially played a role in the more historical infec-
tions in goats, while spread between dairy goat herds is
responsible for the more recent infections and a large
part of the epidemic observed since 2007. The serologi-
cal status of cattle and foremost comparison of C. bur-
netii isolates by subtyping in different ruminant species
might help to elucidate the transmission pathways
between different species of ruminants and to humans.
So far, one unique genotype predominated in dairy
goats herds, although at 50% of the farms at least one
additional genotype was observed [36]. Very sparse data
on cattle isolates in the Netherlands suggest different
subtypes from those found in goats, sheep and humans
[37]. More and nationwide representative data are
urgently needed to confirm these distinct types for cat-
tle, and to study if some cattle types match with the
non-dominant genotypes regularly observed at dairy
goat farms.
Previous ruminant studies have shown that farm man-
agement practices can influence the seroprevalence of C.
burnetii [17,38]. Straw, used widely as bedding in deep
litter stables, could be a way in which Q fever was intro-
duced in the Dutch dairy goat farms as import of straw
from abroad or unknown origin was an independent
risk factor. Farmers indicated straw was most often
imported from Germany and France, which are endemic
countries for Q fever. Microbiological examination from
straw originating from France showed presence of C.
burnetii by PCR, although the method of sampling does
not exclude contaminationa tt h ef a r m[ 3 9 ] .C o n t a c t
with straw and other farm products was also a risk fac-
tor for humans in the first documented outbreak in
2007 and in international outbreak studies [40-42]. The
presence of dogs and cats in the goat stable was related
to a seropositive Q fever status of dairy goat farms.
Furthermore, the seven farms without companion ani-
mals were all seronegative. This suggests introduction of
C. burnetii or facilitation of within farm-spread by
infected companion animals. In a study in Cyprus, risk
factors for Q fever abortions compared to abortions of
other causes were studied in a convenience sample of
ruminant farms including only two goat farms; among
others presence of dogs and cats were on farm risk fac-
tors [38]. Pets, especially during kidding, have been
associated with outbreaks in the past [5,6]. In a Dutch
study in the early 1990s, 13.2% of dogs and 10.4% of
cats tested positive for C. burnetii by ELISA [43]. To
study the role of companion animals in current trans-
mission, an update of this study, ideally also looking at
shedding by PCR, is needed.
Covering airspaces in the stable to control nuisance
animals, such as wild birds, unexpectedly was an inde-
pendent risk factor. As wild birds may play a role in the
transmission within and between farms and were the
cause of a familial Q fever outbreak [44] a protective
effect was expected if any. However, presence of wild
birds in the stable was not a risk factor in the multivari-
able analysis but mainly indicated the farmer actively
controlled nuisance animals such as by covering air-
spaces. In addition, we found at animal level an
increased risk for farms that use windbreak curtain,
sometimes in combination with windshields. These two
risk factors could point at a more air-locked stable, facil-
itating accumulation of C. burnetii inside the stable,
which may promote spread within the herd. This accu-
mulation risk was indirectly shown in the study from
Cyprus where a high frequency of litter cleaning was
found to be a protective factor [38]. Although a less
confined farm might limit the within-herd spread, such
open constructions can be a risk for aerosol spread to
other farms and persons in the near environment. Pre-
sence of mice and rats in the stable was not found to be
a risk factor in our study, although a recent study
showed presence of C. burnetii in rats at livestock farms
in the Netherlands [45]. Whether vermin are able to
maintain the transmission cycle and are able to (re)
introduce Q fever at farms is currently under
investigation.
Conclusions
This study shows that before the start of mandatory vac-
cination of small ruminants in 2009-2010, the seropre-
valence of C. burnetii antibodies in goats at commercial
dairy goat farms has increased compared to a study car-
ried out in 2008 in the Netherlands. The overall goat
prevalence of 21.4% was considerably high, but the farm
prevalence of 43.1% was comparable to generally
observed seroprevalences in other European countries.
On positive dairy goat farms, the within-herd prevalence
was 46.6%, reflecting high circulation of C. burnetii
within a farm and a risk for environmental contamina-
tion and spread. In general, the risk for farms and dairy
goats to acquire a C. burnetii infection seems to be mul-
tifactorial. The two strongest associated risk factors,
proximity of bulk milk-positive small ruminant farms
and a high cattle density, suggest aerosol spread as an
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Page 12 of 14important route of infection of the dairy goat farms.
Furthermore, other risk factors identified possible vehi-
cles for introduction, spreading and/or persistence
within farms, such as import of straw from abroad,
access to the goat stable of cats, dogs and use of artifi-
cial insemination, and covering airspaces of the stable.
Besides, larger farms with 800 or more goats seem to
have an increased risk for infection, although it can not
be concluded that this is entirely due to the size itself
by the larger population at risk, combined with a gen-
eral increased chance of introduction of pathogens in
larger farms or is due to unmeasured farm characteris-
tics strongly related to a large herd size. Based on our
results, it is recommended to further prove the role in
the current transmission of bedding material, goat
semen and excreta from companion animals by micro-
biological testing. Simultaneously, as a precautionary
measure general biosecurity measures should be taken
next to advice on farm stable constructions targeted at
avoiding access of companion animals and how to con-
trol nuisance animals in the goat stables to prevent
introduction and minimizing airborne transmission from
affected farms to prevent spread to humans and other
farms.
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